FIELD: medicine, virology. SUBSTANCE: diagnosis involves the use of peptide composition that is able to bind with antibodies against hepatitis C virus. Composition is tested in indirect variant of immuno-enzyme analysis with serum blood from patients with hepatitis C and from health donors. Use of composition provides 100% detection at 100% specificity. EFFECT: enhanced effectiveness of composition.
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR HEPATITIS C DIAGNOSIS | 1994 |
|
RU2071349C1 |
| DIAGNOSTIC COMPOSITION FOR IDENTIFICATION OF SYPHILIS AND TEST-SYSTEM "AKVASIF" ON ITS BASE | 1998 |
|
RU2137138C1 |
| METHOD OF DETECTION OF ANTIBODY TO HEPATITIS VIRUS C NUCLEAR PROTEIN | 1997 |
|
RU2133622C1 |
| TEST SYSTEM FOR DETECTING ANTIBODIES TO NUCLEAR PROTEIN OF HEPATITIS C OF IGM CLASS | 1997 |
|
RU2142134C1 |
| IMMUNOSORBENT FOR DETECTION OF ANTIBODY TO HEPATITIS C VIRUS NUCLEAR PROTEIN IN BLOOD SERUM | 1997 |
|
RU2138286C1 |
| FUSION PROTEIN | 2016 |
|
RU2748643C2 |
| NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER | 2020 |
|
RU2757353C1 |
| COMPOSITIONS AND METHODS OF TREATING AND PREVENTING HEPATITIS B AND D | 2021 |
|
RU2812764C1 |
| MUTATIONS IN OAS1 GENES | 2006 |
|
RU2465328C2 |
| METHOD AND MEANS FOR RAPID DETECTION OF HEPATITIS D VIRUS INFECTIONS | 2019 |
|
RU2800845C2 |
